Brief Overview

Herbicure is a startup that develops novel herbal products based on Lippia javanica (Zumbane) for use as adjuvant treatments for COVID-19 and other upper respiratory infections (URIs). The product range includes a rub, nasal spray, inhaler, and essential oil extract, which can also be used in cosmetics and as a bug repellent. The business is co-owned by its originators and Midlands State University under a commercialization policy. Herbicure aims to provide natural, safe, and effective alternatives to conventional treatments, with minimal side effects.

Key Milestones and Achievements

• Product Development: Successfully formulated and manufactured rub, nasal spray, inhaler, and essential oil extract.
• Regulatory Progress: Products are at Technology Readiness Level 7, with registration underway with the Traditional Medicines Association and compliance efforts with the Medicines Control Authority of Zimbabwe (MCAZ).
• Market Entry Strategy: Plans for a four-month pre-commercialization phase, followed by sales in herbal pharmacies before expanding further.
• Employment Creation: 13 jobs created within the company.
• Production Expansion: Transitioning from lab-scale production to commercial manufacturing with required equipment procurement underway.
• Projected Sales Growth: Expected total sales revenue of $224,225 over five years, with strong demand for herbal remedies.

Ownership
Dr Ruvimbo Jessy Mapaya

Dr Micheal Bhebhe

Mr Christopher Mabugu

Mrs Merrlyn Mtingwende

Mr Aspire Mtingwende

Ms Lenciana Moyo

Mr Providence Maburitse

Midlands State University (30%)

Expenditure incurred to Date

Revenue Generated to Date